Michael S. Wyand - Concepedia

Author

Michael S. Wyand

Also Known As

M S Wyand, M Wyand, M. S. Wyand, M. WYAND, M. Wyand, M.S. Wyand, MICHAEL S. WYAND, MICHAEL WYAND, Michael S Wyand, Michael S. Wyand

Publications

Citations

H-Index

Concepts

All Affiliations

Harvard University Duke Medical Center Duke University Hospital New England Biolabs (United States)Dana-Farber Cancer Institute

About

Michael S. Wyand is an author at Harvard University specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	22	2.4K
2	Immunology	18	21	2.3K
3	Allergy	5	5	358
4	Education	1	1	74
5	Epidemiology	1	1	33

Michael S. Wyand

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer Philip W. Kantoff, Thomas Schuetz, Brent A. Blumenstein, Journal of Clinical Oncology	2010	969
Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations Harriet L. Robinson, David C. Montefiori, R. Paul Johnson, Nature Medicine VaccinationHuman RetrovirusImmunologyAntiviral ResponseVirology	1999	380
Vaccine protection by a triple deletion mutant of simian immunodeficiency virus Michael S. Wyand, Kelledy Manson, M Garcia-Moll, Journal of Virology ImmunologyPathologySimian Immunodeficiency VirusTwelve Rhesus MonkeysVaccine Target	1996	320
Vaccine protection against simian immunodeficiency virus infection. Ronald C. Desrosiers, Michael S. Wyand, Toshiaki Kodama, Proceedings of the National Academy of Sciences VaccinationVaccinologyVeterinary VaccineVaccine DevelopmentLive Virus Challenge	1989	315
Simian immunodeficiency virus DNA vaccine trial in macaques Shan Lu, James Arthos, David C. Montefiori, Journal of Virology VaccinationVaccine DevelopmentDna PlasmidsRhesus MacaquesVaccine Target	1996	239
Protection by Live, Attenuated Simian Immunodeficiency Virus against Heterologous Challenge Michael S. Wyand, Kelledy Manson, David C. Montefiori, Journal of Virology	1999	223
Highly Attenuated Vaccine Strains of Simian Immunodeficiency Virus Protect against Vaginal Challenge: Inverse Relationship of Degree of Protection with Level of Attenuation R. Paul Johnson, Jeffrey D. Lifson, Susan Czajak, Journal of Virology	1999	218
Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity Kelly Stefano Cole, Joe L. Rowles, B A Jagerski, Journal of Virology Humoral ResponseImmunologySimian Immunodeficiency VirusNeutralization ActivityVaccine Target	1997	154
Simian Immunodeficiency Virus (SIV)<i>gag</i>DNA-Vaccinated Rhesus Monkeys Develop Secondary Cytotoxic T-Lymphocyte Responses and Control Viral Replication after Pathogenic SIV Infection Michael A. Egan, William A. Charini, Marcelo J. Kuroda, Journal of Virology	2000	143
Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys Yasuhiro Yasutomi, Harriet L. Robinson, Shuai Lü, Journal of Virology Primary ImmunodeficiencyVaccinationSystems BiologyDna VaccinationRhesus Monkeys	1996	137

Page 1